4-(Toluene-4-sulfonylamino)-benzoic acid, 95.0%, 1g

3-BROMO-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 97.0%, 1g

6,6'-Dimethyl 5,5'-dibromo-2H,2'H,3H,3'H-[1,1'-biindole]-6,6'-dicarboxylate, 97%, 500mg

4-Nitrophenyl alpha-D-Galactopyranoside [Substrate for alpha-D-Galactosidase]>98.0%(HPLC)200mg

Analytical and precision scale Quintix® series Standard models, not certified, 0.01 g, 410 g, 412-1S

6-Hydroxy-4-(trifluoromethyl)nicotinic acid, 95.0%, 50mg

(S)-1-(5-Bromo-pyridin-2-yl)-ethylaminehydrochloride, 95.0%, 250mg

2'-Deoxycytidine Hydrochloride>98.0%(T)25g

5-(4-ethoxyphenyl)-1,2-oxazole-3-carboxylic acid, 95.0%, 250mg

Potassium tri(1H-imidazol-1-yl)hydroborate, 97.0%, 250mg

6-Amino-7-methoxy-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 98%, 100mg

1-Bromo-2,3-diamino-4-fluorobenzene, 95%, 250mg

3-tert-butyl-1H-pyrazole, 95.0%, 5g